Medicaid expansion was associated with reduced mortality and increased surgical resection rates for patients with #PancreaticCancer, with improvements most evident several years after expansion and for those with stage II-III disease.
https://t.co/4vlqhz8q11
Harvesting more lymph nodes DOES NOT improve survival. It only prevents stage migration. Remember in order for lymphadenectomy to improve survival, you will need N+ and M0 disease. That’s exceedingly rare. PDAC IS A SYSTEMIC DISEASE.
Hepatic histotripsy is a novel noninvasive ultrasound therapy for liver tumors, and 1-yr outcomes demonstrated that local tumor control and survival was consistent with other therapies. https://t.co/cnRCOBwsTG
I’m so excited to share my third and final first-author publication from my PhD!! We discovered NK cells express fibroblast activation protein (FAP) and use it to migrate into tumors! FAP overexpressing NK cells reduced pancreatic cancer growth in mice! https://t.co/SwFuG0BjKb
Interpreting liver mets on MRI can be challenging, in part b/c imaging features (hypo vs hypervascularity) vary by primary tumor site.
I adapted this slide from Dr. Jim Apisarnthanarax presentation at ASTRO.
Important for diagnosing & if treating w MR-guided RT.
Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma#drainage
https://t.co/pWwExgNItL
Congratulations to @VanMorrisMD@MDAndersonNews for his new @Cancer_Cell study:
Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic #ColorectalCancer
https://t.co/UhJTZcQhAc
Thanks for the opportunity to contribute to the study!
Use of a Pathomics Nomogram to Predict Postoperative Liver Metastasis in Patients with Stage III Colorectal Cancer @AnnSurgOncol https://t.co/Su7KLg9Arz
🆕🗞️Hot off the press! @NatureMedicine#KRAS Vaccine💉for patients with RAS➕cancers🎯.
Benefit➡️durable.🙌🏽
More to come with the randomized study📚✔️!
Opens to doors to off the shelf vaccine for so many patients with KRAS/NRAS mutations.
@OncoAlert
🔗https://t.co/ihKZWxGTLE
The striking annual percentage change (APC) for localized early onset #ColorectalCancer in the 45-49 age group after the lowering in age of screening from 50y to 45y.
https://t.co/9BSpoBIIBs
Too many earlier onset CRC are still being missed in the 40-44y age group.
The HPB Surgery Video Library is live!
https://t.co/oUun8QtDUS
Huge thanks to my mentor Dr. Brendan Visser, as well as @MonicaDuaMD , @da_aliseda , and Dr. Jon Harrison for letting me be part of this incredible project
@StanfordSurgery@StanfordGenSurg
Thrilled to welcome 3 outstanding surgeons to the #OhioStateSurg Complex General Surgical Oncology Fellowship. We’re excited to see the impact Dr. Gregory, Dr. Klingbeil & Dr. Standring make! 👏 And a big shoutout to Dr. Gregory, a former Buckeye! Welcome back to THE Ohio State!
Congratulations to the Graduating Chief Class of 2025! 🎉🤩
We are sad to see you leave, but happy to see all you’ve accomplished in the last 5 to 8 years! 🥳 We are so proud to send you onto your next step in this wonderful journey! 🤍
The importance of excersize as part of our treatment plan. 👇🏼👇🏼
Structured Exercise after Adjuvant Chemotherapy for Colon Cancer @NEJM https://t.co/KIbgBDpOdz